Danger signalling during cancer cell death: origins, plasticity and regulation

Autor Garg, A D, Martin, S, Golab, J, Agostinis, P
Vydáno 2014

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

Autor Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, M
Vydáno v Blood Cancer J (2015)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy

Autor Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J
Vydáno 2013

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

Autor Golab, J, Wilczynski, G, Zagozdzon, R, Stoklosa, T, Dabrowska, A, Rybczynska, J, Wasik, M, Machaj, E, Oldak, T, Kozar, K, Kaminski, R, Giermasz, A, Czajka, A, Lasek, W, Feleszko, W, Jakobisiak, M
Vydáno 2000

Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity

Autor Nowis, D, Legat, M, Grzela, T, Niderla, J, Wilczek, E, Wilczyñski, GM, Głodkowska, E, Mrówka, P, Issat, T, Dulak, J, Józkowicz, A, Waś, H, Adamek, M, Wrzosek, A, Nazarewski, S, Makowski, M, Stokłosa, T, Jakóbisiak, M, Gołąb, J
Vydáno 2006